extract: 2024-05-29-nejm-flow-trial-semaglutide-kidney-outcomes
- Factual accuracy — The claims are factually correct, supported by the provided evidence from the SELECT and FLOW trials.
- Intra-PR duplicates — There are no intra-PR duplicates;…
extract: 2021-02-00-mckinsey-facility-to-home-265-billion-shift
Here's my review of the PR:
- Factual accuracy — The claims are factually correct, supported by the provided McKinsey source.
- Intra-PR duplicates — There are no intra-PR…
extract: 2026-03-01-pudgypenguins-retail-distribution-2026-update
Approved (post-rebase re-approval).
extract: 2025-12-23-cms-balance-model-glp1-obesity-coverage
- Factual accuracy — The claims and entities appear factually correct based on the provided evidence.
- Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence…
extract: 2026-02-01-glp1-patent-cliff-generics-global-competition
- Factual accuracy — The claims regarding GLP-1 receptor agonists, their market impact, and the details about patent expirations, generic competition, and new oral formulations appear…
extract: 2026-02-01-coindesk-pudgypenguins-tokenized-culture-blueprint
Approved (post-rebase re-approval).